Targeting The Key Factors Of Inflammation In Cancer: Plant Intervention

Loveth O. Linus,Christian Hanson,Raphael N. Alolga,Wen Zhou,Lianwen Qi

2017-01-01

Abstract:The association between inflammation and cancer has earned significant recognition and acceptance. The activation of genes controlling inflammation cell signaling pathways can lead to the controlling of all aspects of the disease process. Of these pathways, NF-kappa B, STAT-3, HIF-1, TNF-alpha, IL-1, Cox-2 and oncogenic Kinase (IKK, MARK/ERK, Syk/Src, IRAK1/4, JAK, and P13k) play a fundamental role in connecting inflammation and cancer. For this reason, cancer-related inflammation serves as a target for innovative prophylactic and therapeutic intervention. Recently, novel therapeutic concepts aim at interrupting the activity or expression of inflammatory mediators implicated in cancer initiation and promotion, either in single-agent or combinatorial treatment or as supplements of the current therapeutic approach. Phytochemicals and nutraceuticals have achieved noteworthy acknowledgment in the prospective management of various human clinical conditions. Research has demonstrated that plant extracts have proven to be less toxic and very effective chemoprophylactic and therapeutic agents since they possess the ability to suppress specific molecular and cellular pathway in cancer-related inflammation. Therefore, targeting the inflammatory signaling pathways offers the chances to boost the clinical outcome of cancer therapy. Here we provide a new insight into recent advances on the links between inflammation, as they relate to cancer. Also, we reviewed recent findings on plant extracts and phytochemicals that have been scientifically evidenced to exert chemopreventive and chemotherapeutic effect via the inhibition of the key inflammatory events involved in cancer initiation and progression. Our findings highlight the opportunities for future research and further investigation of the identified plants and phytochemical for anti-cancer drug discovery.